High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression

BACKGROUND: High expression of the RNA-binding protein RBM3 has previously been found to be associated with good prognosis in breast cancer, ovarian cancer, malignant melanoma and colorectal cancer. The aim of this study was to examine the prognostic impact of immunohistochemical RBM3 expression in...

Descripción completa

Detalles Bibliográficos
Autores principales: Jonsson, Liv, Gaber, Alexander, Ulmert, David, Uhlén, Mathias, Bjartell, Anders, Jirström, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195697/
https://www.ncbi.nlm.nih.gov/pubmed/21955582
http://dx.doi.org/10.1186/1746-1596-6-91

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195697/
https://www.ncbi.nlm.nih.gov/pubmed/21955582
http://dx.doi.org/10.1186/1746-1596-6-91

Ejemplares similares